Jianguo Sun

1.4k total citations
60 papers, 921 citations indexed

About

Jianguo Sun is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jianguo Sun has authored 60 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Jianguo Sun's work include Cancer Immunotherapy and Biomarkers (16 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Jianguo Sun is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Jianguo Sun collaborates with scholars based in China, United States and Finland. Jianguo Sun's co-authors include Xiewan Chen, Zhengtang Chen, Zihan Xu, Zhengtang Chen, Qiao Yang, Linpeng Zheng, Xinxin Wang, Rongxia Liao, Yu‐zhong Duan and Jie Sun and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Jianguo Sun

58 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianguo Sun China 18 425 333 287 173 125 60 921
Sophie Espenel France 16 300 0.7× 201 0.6× 250 0.9× 139 0.8× 110 0.9× 90 864
Shreyas Joshi United States 16 376 0.9× 552 1.7× 408 1.4× 188 1.1× 90 0.7× 91 1.2k
Norihito Soga Japan 16 277 0.7× 460 1.4× 611 2.1× 129 0.7× 82 0.7× 68 1.2k
Josephine A. Ratikan United States 11 641 1.5× 316 0.9× 374 1.3× 149 0.9× 328 2.6× 16 1.3k
Byoung Yong Shim South Korea 18 596 1.4× 359 1.1× 232 0.8× 182 1.1× 66 0.5× 110 1.0k
Laurentiu M. Pop United States 19 318 0.7× 170 0.5× 297 1.0× 88 0.5× 174 1.4× 41 931
Nerina Denaro Italy 19 558 1.3× 455 1.4× 385 1.3× 283 1.6× 116 0.9× 93 1.4k
Ahmed Younes United States 22 589 1.4× 310 0.9× 301 1.0× 150 0.9× 79 0.6× 60 1.2k

Countries citing papers authored by Jianguo Sun

Since Specialization
Citations

This map shows the geographic impact of Jianguo Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianguo Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianguo Sun more than expected).

Fields of papers citing papers by Jianguo Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianguo Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianguo Sun. The network helps show where Jianguo Sun may publish in the future.

Co-authorship network of co-authors of Jianguo Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jianguo Sun. A scholar is included among the top collaborators of Jianguo Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianguo Sun. Jianguo Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Linpeng, Feng-Lin Lin, Longyao Zhang, et al.. (2025). Single-cell transcriptome sequencing reveals the immune microenvironment in bronchoalveolar lavage fluid of checkpoint inhibitor-related pneumonitis. Cancer Immunology Immunotherapy. 74(4). 128–128.
2.
Wang, Xianli, Zening Wang, Wei Cheng, et al.. (2024). Using integrated transcriptomics and metabolomics to explore the effects of infant formula on the growth and development of small intestinal organoids. Food & Function. 15(18). 9191–9209. 2 indexed citations
4.
Cheng, Ying, Qing Zhou, Baohui Han, et al.. (2023). NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients with metastatic non-small-cell lung cancer. Lung Cancer. 178. 87–95. 6 indexed citations
5.
Chen, Xiewan, et al.. (2023). YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer. Canadian Respiratory Journal. 2023. 1–14. 2 indexed citations
6.
He, Ying, Jian Chen, Ling Long, et al.. (2023). Mental health status and related influencing factors in patients with COVID-19. BMC Psychology. 11(1). 225–225. 3 indexed citations
7.
Chen, Guangpeng, et al.. (2022). Rapid Progress in Intelligent Radiotherapy and Future Implementation. Cancer Investigation. 40(5). 425–436. 8 indexed citations
8.
Tang, Shu, Rong Ye, Dongmei Li, et al.. (2021). Case Report: Long-Term Response to Pembrolizumab Combined With Endocrine Therapy in Metastatic Breast Cancer Patients With Hormone Receptor Expression. Frontiers in Immunology. 12. 610149–610149. 8 indexed citations
9.
Zhou, Yi, Jun Ye, Xiao‐Cheng Wu, et al.. (2021). Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study. BMC Infectious Diseases. 21(1). 760–760. 7 indexed citations
11.
Niu, Kaijun, Xiewan Chen, Yu Qin, et al.. (2021). Celecoxib Blocks Vasculogenic Mimicry via an Off-Target Effect to Radiosensitize Lung Cancer Cells: An Experimental Study. Frontiers in Oncology. 11. 697227–697227. 10 indexed citations
12.
Wang, Jianmin, Yongxin Yu, Linpeng Zheng, et al.. (2019). Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β‐catenin pathway in NSCLC. Cell Proliferation. 52(3). e12592–e12592. 36 indexed citations
13.
Wang, Yang, Xingyun Liao, Jianguo Sun, et al.. (2018). Characterization of HIF‐1α/Glycolysis Hyperactive Cell Population via Small‐Molecule‐Based Imaging of Mitochondrial Transporter Activity. Advanced Science. 5(3). 1700392–1700392. 28 indexed citations
14.
Zhao, Fengyi, Jing Han, Xiewan Chen, et al.. (2016). miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor. International Journal of Molecular Medicine. 38(1). 183–191. 35 indexed citations
16.
Xu, Chunsheng, Jianguo Sun, Haiping Duan, et al.. (2015). Gene, environment and cognitive function: a Chinese twin ageing study. Age and Ageing. 44(3). 452–457. 11 indexed citations
17.
Sun, Jianguo, Feng Ning, Zengchang Pang, et al.. (2014). Cardiovascular risk profiles in relation to newly diagnosed Type 2 diabetes diagnosed by either glucose or HbA1c criteria in Chinese adults in Qingdao, China. Diabetic Medicine. 31(8). 920–926. 5 indexed citations
18.
Liu, Dan, Yanyan Cen, Tao Liu, et al.. (2013). The radiosensitizing effect of CpG ODN107 on human glioma cells is tightly related to its antiangiogenic activity via suppression of HIF-1α/VEGF pathway. International Immunopharmacology. 17(2). 237–244. 17 indexed citations
19.
Harzstark, Andrea, Lawrence Fong, Vivian Weinberg, et al.. (2010). Final results of a phase I study of CTLA-4 blockade in combination with GM-CSF for metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 28(15_suppl). 4689–4689. 13 indexed citations
20.
Xie, Qichao, Yide Hu, Lingli Wang, et al.. (2005). The co-transfection of p16INK4a and p14ARF genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity. Colloids and Surfaces B Biointerfaces. 46(3). 188–196. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026